Biopharmacy Department, Faculty of Pharmacy, Place Henri Dunant, Clermont-Ferrand, France.
Pharm Dev Technol. 2012 May-Jun;17(3):303-14. doi: 10.3109/10837450.2010.535827. Epub 2010 Dec 22.
Pellets and spheres are manufactured in the pharmaceutical industry by various processes which are not always easily automated. In this paper, a 'single pot process' is described using rotary fluid bed granulation with lipid fillers. This technology is based on wet granulation of powder components, continuously suspended in a fluidized air with a tangentially sprayed liquid solution. After a previous work devoted to selection of matrix filler, this work focuses on lipid component: hydrogenated castor oil, used as matrix filler associated with theophylline as tracer. Spheres manufactured can be introduced either directly into a hard gelatine capsule or compressed as tablets. The influence of the formulation and process parameters on the sphere manufacture in terms of feasibility is studied with in vitro tests. Spraying time and weight of liquid sprayed are found to be the most relevant parameters that governed the final quality of the sphere.
微丸和微球在制药工业中通过各种工艺生产,这些工艺并不总是容易实现自动化。本文描述了一种“一锅法工艺”,使用带有脂质填充剂的旋转流化床制粒。该技术基于粉末成分的湿法制粒,连续悬浮在流化空气中,同时喷射切线液体溶液。在之前的工作中,我们致力于选择基质填充剂,这项工作集中在脂质成分上:氢化蓖麻油,用作基质填充剂,与茶碱一起作为示踪剂。所制造的球体可以直接装入硬明胶胶囊中,也可以压缩成片剂。通过体外试验研究了制剂和工艺参数对球体制造可行性的影响。发现喷雾时间和喷雾的液体重量是控制球体最终质量的最相关参数。